FDA June 2026 enforcement update — compounding pharmacies

Dr.SurgeonPGH said:

Resolution therefore closed the doors unevenly, and the asymmetry follows from the bulks lists.

This is exactly what I could not find anywhere else. Sending this to two other people who asked me the same thing last week.

From the other side of the consultation, briefly.

Vendor communication red flags for compounded supply:

• Won't provide COA before purchase — walk away
• Claims "100% pure" without analytical data — unrealistic
• No physical address or phone number — accountability matters
• Pushes you to buy more than you need — pressure tactics
• Won't answer questions about their compounding process — transparency is key
• Payment only via crypto or wire transfer — legitimate pharmacies accept cards

A legitimate compounding pharmacy operates like a healthcare business, not a gray market dealer.

NurseLeah_Nash said:

They are two different exemptions from the same federal requirements and they buy different things.

Compounded has been just as effective for me. If compounded supply is the concern, the COA from my 503B pharmacy shows 99.1% purity. Verified by Janoshik.

RegAffairsDC said:

FDA June 2026 enforcement update — compounding pharmacies Pinned because it affects plans people have already made, not because it is dramatic.

I have been on both brand and compounded, and in the context of compounded supply, my experience has been equivalent with both. The key is finding a reliable 503B pharmacy with independent testing.

Moderator note: the sourcing question belongs in the vendor section and has been split out. Report rather than reply if it drifts again.